Boston Business Journal -- Cambridge-based biotechnology company Cequent Pharmaceuticals has raised $2.7 million of a planned $10.8 million financing round. The funding included investments from Wellesley, Mass.-based Ampersand Ventures, New England Capital Partners in Newton, Mass., and Durham, N.C.-based A.M. Pappas Life Science Ventures.
